SHE:002294 Revenue

In the year 2024, Shenzhen Salubris Pharmaceuticals had annual revenue of 4.01B CNY with 19.22% growth. Shenzhen Salubris Pharmaceuticals had revenue of 1.01B in the quarter ending December 31, 2024, with 11.23% growth.

Revenue

4.01B

Revenue Growth

+19.22%

P/S Ratio

9.40

Revenue / Employee

1.14M

Employees

3,517

Market Cap

37.73B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	4.01B	646.89M	19.22%
Dec 31, 2023	3.37B	-116.67M	-3.35%
Jan 1, 2023	3.48B	423.62M	13.85%
Jan 1, 2022	3.06B	319.83M	11.68%
Dec 31, 2020	2.74B	-1.73B	-38.74%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Jiangsu Hengrui Medicine	27.98B
Shenzhen Mindray Bio-Medical Electronics	37.11B
WuXi AppTec	37.92B
Aier Eye Hospital Group	20.62B
Zhangzhou Pientzehuang Pharmaceutical.,	10.91B
Yunnan Baiyao Group Co.,Ltd	40.03B
Shanghai United Imaging Healthcare	10.30B
Sichuan Biokin Pharmaceutical	5.82B

Revenue Rankings